SLC18A2 Back

solute carrier family 18 (vesicular monoamine), member 2

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of SLC18A2

The vesicular monoamine transporter acts to accumulate cytosolic monoamines into synaptic vesicles, using the proton gradient maintained across the synaptic vesicular membrane. Its proper function is essential to the correct activity of the monoaminergic systems that have been implicated in several human neuropsychiatric disorders. The transporter is a site of action of important drugs, including reserpine and tetrabenazine (summary by Peter et al., 1993 [PubMed 7905859]). See also SLC18A1 (MIM 193002).[supplied by OMIM, Jan 2011]. Sequence Note: This RefSeq record was created from transcript and genomic sequence data to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on transcript alignments.

Community Annotation of SLC18A2 Add / Edit SLC18A2: Annotations

No community annotations yet for SLC18A2.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes

• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


SLC18A2 is highly significantly mutated in
SLC18A2 is significantly mutated in
SLC18A2 is near significance in

Click on a tumor type to see its full list of significant genes.

Data details

Mutation list for SLC18A2